Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure
Patent
1993-05-17
1996-08-27
Naff, David M.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
426335, 426532, A61K 3500, A21D 400, A23L 334
Patent
active
055498957
ABSTRACT:
The invention is directed toward strains of Escherichia coli which produce a colicin effective in inhibiting the growth of pathogenic Enterobacteriaceae including E. coli strain 0157:H7, and the colicin derived from those strains of E. coli. The invention also provides methods of using the colicin to inhibit the growth of pathogenic Enteriobacteriaceae in food substances and on hard surfaces.
REFERENCES:
patent: 4861754 (1989-08-01), Farkas-Hinsley
patent: 5043176 (1991-08-01), Bycroft et al.
Bradley et al, "Colicinogeny of O157:H7 enterohemorrhagic Escherichia coli and the shielding of colicin and phage receptors by their O-antigenic side chains" Canadian Journal of Microbiology37:97-104 (1991).
Nielsen J. W. et al, App Environ Microbiol. 56:2142-2145 (1990).
Degnan et al, J. food Protection 55:552-554 (1992).
Hoover D G, Encyclopedia of Microbiology vol. 1:181-190 (1992).
Barnby-Smith F M, Trends in Food Science & Technology 3(6):133-137 (1992)
M. Daeshel, "Antimicrobial Substances from Lactic Acid Bacteria for Use as Food Preservatives", Food Technology,43:164-166 (1989).
Determinative Bacteriology, John G. Holt, ed., Williams & Wilkins Company, Baltimore, MD at pp. 100-102 (1977).
H. P. Fleming et al., "Microbial Inhibition by an Isolate of Pediococcus from Cucumber Brines", Appl. Microbiol., 30:1040-1042 (1975).
P. Frederico, "Colicins", Rev. Belg. Pathol. Med. Exp., 29:7-10 (1948).
H. R. Herschman et al., "Purification and Characterization of Colicin E.sub.2 and Colicin E.sub.3 ", J. Biol. Chem.242:5360 (1967).
J. H. Keene, "Preparation and Chemical Properties of Colicine I", Canadian J. Microbiol.12:425-427 (1966).
U. K. Laemmli, "Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4", Nature, 227:680-685 (1970).
O. H. Lowry et al., "Protein Measurement with the Folin Phenol Reagent", Biol. Chem.,193:265-275 (1951).
W. J. Lyon et al., "Partial Purification and Characterization of a Bacteriocin Produced by Propionibacterium thoenii", Appl. Environ. Microbiol., 57:701-706 (1991).
W. J. Lyon et al., "Isolation and Purification of Propionicin PLG-1, a Bacteriocin Produced by a Strain of Propionibacterium theoenii", Appl. Envir. Microbiol., 59:83-88 (1993).
N. Mermelstein, "Controlling E. coli 0157:H7 in Meat", Food Technol.,47:90-91 (1993).
C. R. Merril et al, "Ultrasensitive Strain for Proteins in Polyacrylamide Gels Shows Regional Variation in Cerebrospinal Fluid Proteins", Science, 211: 1437-1438 (1981).
R. Nickelson II, "E. coli 0157:H7 --A Pathogen of Renewed Concern", Scope, 50002:6-7 (1993).
J. R. Tagg et al., "Assay System for Bacteriocins", Appl. Microbiol., 21:943 (1971).
Lyon Wanda J.
Murano Elsa A.
Olson Dennis G.
Iowa State University & Research Foundation, Inc.
Naff David M.
Saucier Sandra
LandOfFree
Method and colicin composition for inhibiting Escherichia coli 0 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and colicin composition for inhibiting Escherichia coli 0, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and colicin composition for inhibiting Escherichia coli 0 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1054844